Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study

In this prospective phase II clinical trial, multiple myeloma (MM) patients were randomized to receive a second (tandem) autologous stem cell transplantation (ASCT) based on whether they achieved a partial response or worse (≤PR) following initial ASCT (ASCT1). Patients who achieved a very good part...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrne, Michael, Salmasinia, Donya, Leather, Helen, Cogle, Christopher R, Davis, Amy, Hsu, Jack W, Wiggins, Laura, Chang, Myron N, An, Qi, Wingard, John R, Moreb, Jan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159376/
https://www.ncbi.nlm.nih.gov/pubmed/25232286
http://dx.doi.org/10.4137/CMO.S16835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159376/
https://www.ncbi.nlm.nih.gov/pubmed/25232286
http://dx.doi.org/10.4137/CMO.S16835

Ejemplares similares